Merrimack stock rockets 200% after positive trial data on Onivyde pancreatic cancer treatment Shares of Merrimack Pharmaceuticals Inc. skyrocketed 199.5% toward a 4 1/2-year high in morning trading Wednesday, after the France-based…
Merrimack Pharmaceuticals Shares Soar Premarket on Ipsen Study Success >MACK Merrimack Pharmaceuticals Shares Soar Premarket on Ipsen Study Success >MACK...…
Ipsen S.A. reports Q3 results; reaffirms FY22 guidance Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Navamedic ASA launches ForlaxGO® - an innovative on-the-go product for the treatment of constipation Oslo, 20 October 2022 – Navamedic ASA (OSE: NAVA) today announces the launch of ForlaxGO® across pharmacies in Norway, Sweden,…